BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BAT3306 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BAT3306\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07180862-2098@assetmemo.bio
DTSTAMP:20261121T004533Z
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270301
SUMMARY:BAT3306: Phase 1 readout est. (NCT07180862)
DESCRIPTION:BAT3306\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Study
  Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants\
 nEstimated primary completion: 28 February 2027. This is a ClinicalTrials.
 gov estimate\, not a confirmed readout date\, and it can move.\nDrug page:
  https://assetmemo.bio/drug/bat3306#upcoming-events\nRegistry record: http
 s://clinicaltrials.gov/study/NCT07180862
URL:https://assetmemo.bio/drug/bat3306#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
